MRPL35 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.989400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.635200E-01
Normal-vs-Stage2
9.944600E-01
Normal-vs-Stage3
4.578400E-01
Normal-vs-Stage4
6.869600E-01
Stage1-vs-Stage2
4.178200E-01
Stage1-vs-Stage3
2.514400E-01
Stage1-vs-Stage4
9.342600E-01
Stage2-vs-Stage3
2.385000E-01
Stage2-vs-Stage4
5.827800E-01
Stage3-vs-Stage4
2.877600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.741400E-01
Normal-vs-AfricanAmerican
9.718000E-01
Normal-vs-Asian
6.509000E-01
Caucasian-vs-AfricanAmerican
9.996000E-01
Caucasian-vs-Asian
4.008600E-01
AfricanAmerican-vs-Asian
5.354600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.727800E-01
Normal-vs-Female
9.603800E-01
Male-vs-Female
7.461800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.172000E-01
Normal-vs-Age(41-60Yrs)
7.423400E-01
Normal-vs-Age(61-80Yrs)
8.676600E-01
Normal-vs-Age(81-100Yrs)
8.912200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.136400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.689800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.529400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.395800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.568400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.424000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.917200E-01
Normal-vs-Daily Drinker
6.054800E-01
Normal-vs-Weekly Drinker
7.282600E-01
Normal-vs-Occasional Drinker
6.288000E-01
Normal-vs-Social Drinker
5.275400E-01
Non Drinker-vs-Daily Drinker
9.212200E-01
Non Drinker-vs-Weekly Drinker
6.742400E-01
Non Drinker-vs-Occasional Drinker
4.401700E-02
Non Drinker-vs-Social Drinker
2.641700E-02
Daily Drinker-vs-Weekly Drinker
6.498400E-01
Daily Drinker-vs-Occasional Drinker
6.310300E-02
Daily Drinker-vs-Social Drinker
4.235900E-02
Weekly Drinker-vs-Occasional Drinker
1.559760E-01
Weekly Drinker-vs-Social Drinker
1.027960E-01
Occasional Drinker-vs-Social Drinker
7.084400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.913600E-02
Normal-vs-Grade 2
2.699700E-02
Normal-vs-Grade 3
2.672000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.025200E-01
Grade 1-vs-Grade 3
2.139200E-01
Grade 1-vs-Grade 4
6.913600E-02
Grade 2-vs-Grade 3
6.694000E-01
Grade 2-vs-Grade 4
2.699700E-02
Grade 3-vs-Grade 4
2.672000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.696800E-01
Normal-vs-NonDiabetic
8.504000E-01
Diabetic-vs-NonDiabetic
6.645600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.097000E-01
Normal-vs-NoPancreatitis
7.799800E-01
Pancreatitis-vs-NoPancreatitis
3.150400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.661800E-01
Normal-vs-N1
9.823800E-01
N0-vs-N1
4.866200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.207600E-01
Normal-vs-TP53-NonMutant
8.050000E-01
TP53-Mutant-vs-TP53-NonMutant
5.701800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
